These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. THE EFFECT OF TOPICAL FLUOCINOLONE ACETONIDE AND NEARLY TOTAL BODY OCCLUSIVE DRESSINGS ON THE URINARY EXCRETION OF NITROGEN, SODIUM, POTASSIUM, 17-KETOSTEROIDS AND 17-HYDROXYSTEROIDS. MYERSON RM Am J Med Sci; 1964 Oct; 248():441-4. PubMed ID: 14210316 [No Abstract] [Full Text] [Related]
44. FLUOCINOLONE ACETONIDE IN AN OINTMENT BASE: A CLINICAL EVALUATION. DICK LA Skin (Los Angeles); 1963 Dec; 2():371-3. PubMed ID: 14088565 [No Abstract] [Full Text] [Related]
45. [THERAPY OF VARIOUS TYPES OF ECZEMA WITH FLUOCINOLONE ACETONIDE HYDROPHILIC OINTMENT]. FUKUHARA M; SONODA S Hifuka Kiyo; 1963 Mar; 58():103-5. PubMed ID: 14045192 [No Abstract] [Full Text] [Related]
47. [HISTOLOGY AND HISTOCHEMISTRY OF PSORIASIC LESIONS TREATED BY OCCLUSIVE DRESSINGS WITH A FLUORANDRENOLONE BASE]. BRAUN-FALCO O; THIANPRASIT M; KINT A Bull Soc Fr Dermatol Syphiligr; 1963; 70():235-8. PubMed ID: 14075191 [No Abstract] [Full Text] [Related]
48. [Epidermal DNA synthesis under occlusive dressings in the tritium-thymidine autoardiogram]. Born W Z Haut Geschlechtskr; 1969 May; 44(9):305-10. PubMed ID: 5772389 [No Abstract] [Full Text] [Related]
49. [CONTRIBUTION TO THE EXTERNAL THERAPY OF PSORIASIS WITH FLUOCINOLONE ACETONIDE (JELLIN)]. STURDE HC; REICHENBERGER M Munch Med Wochenschr; 1963 Nov; 105():2237-9. PubMed ID: 14109933 [No Abstract] [Full Text] [Related]
50. [TREATMENT OF LICHENOID DERMATOSES WITH OCCLUSIVE FOIL DRESSINGS]. STEGMANN W Munch Med Wochenschr; 1965 Feb; 107():343-6. PubMed ID: 14260296 [No Abstract] [Full Text] [Related]
51. [PURPURIC VERGETURES AFTER LOCAL CORTICOTHERAPY UNDER OCCLUSIVE TREATMENT]. GRUPPER MC; SEGAL Bull Soc Fr Dermatol Syphiligr; 1964; 71():479-82. PubMed ID: 14210514 [No Abstract] [Full Text] [Related]
53. [COMPARATIVE STUDIES ON EXTERNAL CORTICOSTEROIDS. THE PRO AND CON OF THE ANTIBIOTIC ADDITIVE]. SIMONS RD Hautarzt; 1964 Jun; 15():287-94. PubMed ID: 14234732 [No Abstract] [Full Text] [Related]
54. Outpatient treatment of psoriasis. A double-blind trial of ointments. Allenby CF; Munroàshman EJ; Wells RS; Barr A Lancet; 1966 Jan; 1(7429):124-5. PubMed ID: 4158954 [No Abstract] [Full Text] [Related]
56. SOME QUANTITATIVE FACTORS IN TOPICAL CORTICOSTEROID THERAPY. SCHOLTZ JR; NELSON DH Clin Pharmacol Ther; 1965; 6():498-509. PubMed ID: 14314974 [No Abstract] [Full Text] [Related]
57. [EXPERIENCES WITH A NEW LOCAL CORTICOSTEROID (FLUOCINOLINE ACETONIDE)]. HARTMANN W Ther Ggw; 1963 Oct; 102():1203-8. PubMed ID: 14096251 [No Abstract] [Full Text] [Related]
58. [Fluocinolone-plastic therapy and conservative treatment of severe psoriasis]. Knudsen EA Ugeskr Laeger; 1965 Dec; 127(50):1619-21. PubMed ID: 5868339 [No Abstract] [Full Text] [Related]
59. A COMPARISON OF FLUOCINOLONE AND TRIAMCINOLONE ACETONIDES. CHALMERS D; MORLEY WN Br J Dermatol; 1963 Jul; 75():278-9. PubMed ID: 14046147 [No Abstract] [Full Text] [Related]
60. [A comparison of steroids in the topical treatment of psoriasis]. Groth O; Juhlin L; Michaëlsson G; Ohman S Lakartidningen; 1966 Sep; 63(37):3432-9. PubMed ID: 5331716 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]